Psychedelic Session Triggers Temporary Speech Revival in Advanced Alzheimer’s Case

An octogenarian with advanced Alzheimer’s showed a temporary return of fluent speech and personal-memory recall about 19 hours after a supervised 5-gram psilocybin dose, with weeks of improved alertness and independence, and a second supervised 3-gram session suggesting further benefit. This is a single uncontrolled case with no biomarkers, so it does not prove efficacy or safety and cannot be generalized; potential mechanisms include 5-HT2A receptor signaling, increased BDNF, dendritic spine growth, and temporary restructuring of brain networks, highlighting the need for controlled trials and caution against unsupervised use.